Supply of Hydrocortisone Injection
A Contract Award Notice
by DEPARTMENT OF HEALTH AND SOCIAL CARE
- Source
- OJEU
- Type
- Contract (Supply)
- Duration
- 3.5 month (est.)
- Value
- £413K
- Sector
- HEALTH
- Published
- 23 Apr 2021
- Delivery
- 15 Feb 2021 to 07 Jun 2021 (est.)
- Deadline
- n/a
Concepts
Location
London
2 buyers
1 supplier
- Pfizer Kent
Description
The Department of Health and Social Care (DHSC) has awarded Contract for the Supply of Hydrocortisone Injection for Covid-19.
Total Quantity or Scope
The Department of Health and Social Care conducted a Open accelerated procedure under the Regulation 27(5) of the Public Contracts Regulations 2015 (as amended) for the supply of hydrocortisone sodium succinate 100 mg powder for solution for injection vials or hydrocortisone sodium succinate 100 mg powder and solvent for solution for injection vials. The contract period expires on 11 June 2021.
Award Detail
| 1 | Pfizer (Kent)
|
Renewal Options
Have the option to extend the contract for up to an additional 4 months.
Award Criteria
| Quality | _ |
| Risk — Management plan | _ |
| Risk — Condition of contracts | _ |
| Delivery date | _ |
| Price | _ |
CPV Codes
- 33600000 - Pharmaceutical products
Indicators
- Options are available.
- Award on basis of price and quality.
Legal Justification
The Covid-19 outbreak has given rise to an urgent need for the supply of Hydrocortisone injection vials because the authority needs to be in a position to treat the population as required. This does not give the authority sufficient time to comply with the standard open procedure time scales for this procurement. The authority considers this to be a state of urgency which it has duly substantiated. Accordingly, the authority is using the accelerated time limits permitted under the Public Contract Regulations 2015 (Regulation 27(5) for the open procedure) in respect of this procurement.
Reference
- OJEU 204721-2021